TipRanks
Mannkind Corp. (MNKD)
NASDAQ:MNKD
US Market
Want to see MNKD full AI Analyst Report?

MannKind (MNKD) Drug Pipeline

2,111 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Nintedanib Dry Powder Inhalation
Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (Ipf)
Phase II
Recruiting
Phase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With Idiopathic Pulmonary Fibrosis
Jun 18, 2026
―
Mnkd-201
Idiopathic Pulmonary Fibrosis (Ipf)
Phase I
Completed
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis
Jan 07, 2026
Basal Insulin, Technosphere Insulin
Type 1 Diabetes Mellitus
Phase II
Recruiting
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
Oct 31, 2025
Mknd-201
Healthy Volunteers
Phase I
Recruiting
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MKND-201 in Healthy Volunteers
Jul 26, 2024
―
Clofazimine Inhalation Suspension
Mac Lung Disease, Treatment Refractory Mac Lung Disease, Mycobacterium Infections, Nontuberculous
Phase III
Terminated
ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension
May 08, 2024
Insulin Degludec, Basal Insulin, Afrezza, Rapid-Acting Insulin Analog
Diabetes Mellitus, Type 1
Phase IV
Completed
INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes
Jun 02, 2023
―
Insulin Degludec, Afrezza Inhalation Powder, Continuous Subcutaneous Insulin Infusion Pump With Automatic Insulin Delivery
Type 1 Diabetes
Phase IV
Completed
Afrezza With Basal Combination (ABC): Afrezza® Combined With AID Pump or Insulin Degludec in Adults With Type 1 Diabetes
Feb 07, 2022
―
Basal Insulin, Afrezza, Rapid-Acting Insulin Analog
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Phase III
Completed
Afrezza® INHALE-1 Study in Pediatrics
Jun 22, 2021
―
Afrezza Dose 1, Afrezza Dose 2
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Phase IV
Completed
Afrezza® Dosing Optimization Study
Apr 16, 2021
―
Afrezza Inhalant Product
Type 2 Diabetes Treated With Insulin
Phase IV
Unknown
A Study to Evaluate Time in Range in Type 2 Diabetics Using Afrezza® Plus Basal Insulin Compared to Multiple Daily Injections
Oct 09, 2019
―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Mannkind Corp. (MNKD) have in its pipeline
      MNKD is currently developing the following drugs: Nintedanib Dry Powder Inhalation, Mnkd-201, Basal Insulin, Technosphere Insulin. These drug candidates are in various stages of clinical development as the company works toward FDA approval.